More on GRAL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $75.11 |
|
|||
| Open | $75.29 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $81.76 | ||||
| Day Low | $75.29 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 975,090 | ||||
- RBC Capital Starts GRAIL, Inc. (GRAL) at Sector Perform
- UBS Assumes GRAIL, Inc. (GRAL) at Buy
- GRAIL, Inc. (GRAL) PT Raised to $86 at Baird
- Form 144 GRAIL, Inc. Filed by: Ofman Joshua J.
- Form 144 GRAIL, Inc. Filed by: Freidin Aaron
- Form SCHEDULE 13G/A GRAIL, Inc. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
- FDA panel set to review GRAIL's multi-cancer blood test application
- GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
- Form SCHEDULE 13G GRAIL, Inc. Filed by: STATE STREET CORP
- Form SCHEDULE 13G/A GRAIL, Inc. Filed by: PRIMECAP MANAGEMENT CO/CA/
Entities mentioned with GRAL
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Morgan Stanley | View Related Stories »
- Show More...
